CARYX
Price
$10.68
Change
-$0.03 (-0.28%)
Updated
Sep 17 closing price
Net Assets
2.5B
DRRAX
Price
$16.38
Change
+$0.01 (+0.06%)
Updated
Sep 17 closing price
Net Assets
864.36M
Interact to see
Advertisement

CARYX vs DRRAX

Header iconCARYX vs DRRAX Comparison
Open Charts CARYX vs DRRAXBanner chart's image
Columbia Adaptive Risk Allocation Inst3
Price$10.68
Change-$0.03 (-0.28%)
VolumeN/A
Net Assets2.5B
BNY Mellon Global Real Return - A
Price$16.38
Change+$0.01 (+0.06%)
VolumeN/A
Net Assets864.36M
CARYX vs DRRAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CARYX vs. DRRAX commentary
Sep 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CARYX is a Hold and DRRAX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CARYX has more cash in the bank: 2.5B vs. DRRAX (864M). DRRAX pays higher dividends than CARYX: DRRAX (4.82) vs CARYX (2.34). CARYX was incepted earlier than DRRAX: CARYX (11 years) vs DRRAX (15 years). DRRAX (1.24) is less costly to investors than CARYX (0.77). CARYX is a more actively managed with annual turnover of: 186.00 vs. DRRAX (77.47). DRRAX has a lower initial minimum investment than CARYX: DRRAX (1000) vs CARYX (1000000). CARYX annual gain was more profitable for investors over the last year : 9.95 vs. DRRAX (7.77). DRRAX return over 5 years is better than : 20.22 vs. CARYX (12.34).
CARYXDRRAXCARYX / DRRAX
Total Expense Ratio0.771.1865%
Annual Report Gross Expense Ratio0.771.2462%
Fund Existence11 years15 years-
Gain YTD11.9127.274164%
Front LoadN/A6%-
Min. Initial Investment10000001000100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets2.5B864M290%
Annual Yield % from dividends2.344.8248%
Returns for 1 year9.957.77128%
Returns for 3 years28.5916.68171%
Returns for 5 years12.3420.2261%
Returns for 10 years38.8446.0584%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSPTX37.87N/A
N/A
Goldman Sachs Large Cap Equity Inv
NCIGX33.32N/A
N/A
Nuveen International Value C
MGPIX111.15N/A
N/A
ProFunds Mid Cap Growth Inv
VZICX33.28N/A
N/A
Vanguard International Core Stock Adm
VVIEX14.19N/A
N/A
VOYA VACS Index Series EM Portfolio